PubMed Health⌕ Search

Biomedical subjects

R Drapkin

Publications and source records attributed to R Drapkin.

23 records · Page 2Linked to original sources

Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II.

The RNA polymerase II general transcription factor TFIIH is composed of several polypeptides. The observation that the largest subunit of TFIIH is the excision-repair protein XPB/ERCC3 (ref. 1), a helicase implicated in the human DNA-repair disorders xeroderma pigmentosum (XP) and Cockayne's syndrome, suggests a functional link between transcription and DNA repair. To understand the connection between these two cellular processes, we have extensively purified and functionally analysed TFIIH. We find that TFIIH has a dual role, being required for basal transcription of class II genes and for participation in DNA-excision repair. TFIIH is shown to complement three different cell extracts deficient in excision repair: XPB/ERCC3, XPC and XPD/ERCC2. The complementation of XPB and XPD is a consequence of ERCC3 and ERCC2 being integral subunits of TFIIH, whereas complementation of XPC is due to an association of this polypeptide with TFIIH. We found that the general transcription factor IIE negatively modulates the helicase activity of TFIIH through a direct interaction between TFIIE and the ERCC3 subunit of TFIIH.

DNA Helicases↗

The multifunctional TFIIH complex and transcriptional control.

RNA polymerase II (Pol II) requires seven general transcription factors (GTFs) and ATP for transcription initiation. Transcription factor IIH (TFIIH) has emerged as the sole GTF with enzymatic activity. In addition to its essential role in transcription initiation, recent studies have demonstrated a direct involvement of TFIIH in DNA excision repair processes. The enzymatic properties and functional duality of TFIIH make it a prime target for regulation by viral and cellular factors.

Amino Acid Sequence↗

Regulation of RNA polymerase II transcription.

Transcription initiation plays a central role in the regulation of gene expression. Exciting developments in the last year have furthered our understanding of the interactions between general transcription factors and how these factors respond to modulators of transcription.

Animals↗

Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.

Forty previously untreated patients with stage III non-small cell bronchogenic carcinoma were treated with doxorubicin (Adriamycin) at a dose of 60 mg/m2 iv on Day 1 and cisplatin (cis-diamminedichloroplatinum[II]) at a dose of 60-80 mg/m2 iv on Day 1, every 4 weeks. Each patient was randomized to receive iv Corynebacterium parvum either on Day 1 or on Day 14 of each 4-week cycle. There were no complete responses and only seven of 40 (17.5%) patients achieved a partial response, with an overall median survival of 23 weeks. Those patients with stable disease survived longest. There was no difference in median survival among those patients receiving C. parvum on Day 1 (25 weeks) and among those receiving C. parvum on Day 14 (17 weeks).

Adult↗